$LLY Eli Lilly Q3 earnings adjusted EPS $7.48, estimated $5.59.
Rev. $24.40B, estimated $22.52B.
Mungero rev. $10.7B, estimated $9.95B.
Zepbound rev. $5.35B, estimated $5.01B.
Fundayo rev. $184 million, estimate $231.2 million.
Acquired IPR&D charges $4.57 per share.
Sees FY rev. $91B to $92B, see $85B to $87B.
sees FY Adj.